Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.75 |
| ▸ | BCHE | P06276 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MPO | P05164 | 2/20 | 0.47 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29938949 | 1.00 | ACHE (0.75) | ACHEBCHEALDH1A1TSHRGFER | |
| Hydrochloric Acid SCHEMBL9583051 | 0.98 | ACHE (0.76) | ACHEBCHEALDH1A1TSHRGFER | |
| SCHEMBL28837434 | 0.86 | ACHE (1.00) | ACHEALDH1A1TSHRGFERDRD2 | |
| SCHEMBL2013061 | 0.85 | CYP2C9 (0.62) | ACHEALDH1A1MAOAKDM4EMPO | |
| SCHEMBL13495620 | 0.82 | SMN1; SMN2 (0.67) | ACHEALDH1A1DRD2MAOAKDM4E | |
| SCHEMBL6347632 | 0.81 | ACHE (0.64) | ACHEBCHEALDH1A1TSHRGFER | |
| SCHEMBL3158244 | 0.80 | ACHE (0.62) | ACHEALDH1A1TSHRGFERDRD2 | |
| Hydrochloric Acid SCHEMBL6339656 | 0.80 | ACHE (0.65) | ACHEALDH1A1TSHRGFERDRD2 | |
| SCHEMBL14423575 | 0.79 | ACHE (0.54) | ACHEBCHEALDH1A1TSHRGFER | |
| SCHEMBL2010740 | 0.79 | ACHE (0.65) | ACHEALDH1A1TSHRGFERDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5073173-A | Oxidative hair dye mixture | CLAIROL INCORPORATED (US) | 1991-12-17 | — | — | US | claimed |
| EP-0398702-A2 | Dye couplers | Bristol-Myers Squibb Company (US) | 1990-11-22 | — | — | EP | claimed |
| US-20220283032-A1 | Hair Colorant Assessment, Selection And Formulation System | Innovative Beauty LLC (US) | 2022-09-08 | — | — | US | disclosed |
| US-11378457-B1 | Hair colorant assessment, selection and formulation system | Innovative Beauty LLC (US) | 2022-07-05 | — | — | US | disclosed |
| US-11137291-B1 | Hair colorant assessment, selection and formulation system | Innovative Beauty LLC (US) | 2021-10-05 | — | — | US | disclosed |
| US-8680095-B2 | Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2014-03-25 | — | — | US | disclosed |
| US-20120283256-A1 | NEW HETEROCYCLE COMPOUNDS AND USES THEREOF FOR THE PREVENTION OR TREATMENT OF DISEASES INVOLVING FORMATION OF AMYLOID PLAQUES AND/OR WHERE A DYSFUNCTION OF THE APP METABOLISM OCCURS | UNIVERSITE LILLE 1 - SCIENCES ET TECHNOLOGIES (FR) | 2012-11-08 | — | — | US | disclosed |
| EP-2513062-A1 | 7-CHLORO-QUINOLIN-4-AMINE COMPOUNDS AND USES THEREOF FOR THE PREVENTION OR TREATMENT OF DISEASES INVOLVING FORMATION OF AMYLOID PLAQUES AND/OR WHERE A DYSFUNCTION OF THE APP METABOLISM OCCURS | Institut National de la Santé et de la Recherche Médicale (FR) | 2012-10-24 | — | — | EP | disclosed |
| WO-2011073322-A1 | 7-CHLORO-QUINOLIN-4-AMINE COMPOUNDS AND USES THEREOF FOR THE PREVENTION OR TREATMENT OF DISEASES INVOLVING FORMATION OF AMYLOID PLAQUES AND/OR WHERE A DYSFUNCTION OF THE APP METABOLISM OCCURS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2011-06-23 | — | — | WO | disclosed |
| US-5183941-A | Aminophenol | CLAIROL INCORPORATED (US) | 1993-02-02 | — | — | US | disclosed |
| US-5073173-A | Oxidative hair dye mixture | CLAIROL INCORPORATED (US) | 1991-12-17 | — | — | US | disclosed |
| EP-0398702-A2 | Dye couplers | Bristol-Myers Squibb Company (US) | 1990-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283256-A1 | NEW HETEROCYCLE COMPOUNDS AND USES THEREOF FOR THE PREVENTION OR TREATMENT OF DISEASES INVOLVING FORMATION OF AMYLOID PLAQUES AND/OR WHERE A DYSFUNCTION OF THE APP METABOLISM OCCURS | APP, BACE1, PSEN1 | ACHE 66/4885BCHE 31/4885ALDH1A1 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.